Letrozole and Metronomic Capecitabine in ER-positive HER2 Negative Advanced Breast Cancer (B-001 Study)
Clinical trial NCT04571437 · UNKNOWN
Trial details
- NCT number
- NCT04571437
- Sponsor
- Cairo University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-01
- Primary completion
- 2021-10-31
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.